11 earlier Form 4 trades (code P or S) here by this insider (11 sales), the last on Feb 28, 2025.
The trade is 3.7% of the 806,873 shares held after it.
No other insider sold within 30 days.
276 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRESIDENT AND CEO Lowe Eugene Joseph III sold about $6.7M of SPXC on Mar 2, 2026, the largest insider sale at the company since 2025; 276 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Jun 24, 2024.
The trade is 0.8% of the 49,620 shares held after it.
1 other insider sold within 30 days.
276 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRES., HEATING AND GLOBAL OPER Data J Randall sold about $85.6K of SPXC on Dec 11, 2025; 1 other insider sold within 30 days and 276 funds added in the latest 13F quarter.
16 earlier Form 4 trades (code P or S) here by this insider (16 sales), the last on Jun 24, 2024.
The trade is 0.8% of the 38,020 shares held after it.
1 other insider sold within 30 days.
276 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: PRES., HEATING AND GLOBAL OPER Data J Randall sold about $65.6K of SPXC on Dec 11, 2025; 1 other insider sold within 30 days and 276 funds added in the latest 13F quarter.
77 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SPXC planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
SPXC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Value Line Small Cap Opportunities Fund, Inc.
$35.8M position · as of 2026-06-30
4.3%
Tema U.S. Manufacturing & Reshoring ETF
$10.4M position · as of 2026-05-31
3.8%
CONESTOGA SMID CAP FUND
$17.0M position · as of 2026-06-30
3.6%
Osterweis Opportunity Fund
$13.3M position · as of 2026-06-30
3.5%
Artisan Small Cap Fund
$29.9M position · as of 2026-06-30
3.1%
ALGER SMALL CAP FOCUS FUND
$26.0M position · as of 2026-07-31
3.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Eugene Lowe
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$9.3M
$20.1M
$2.2M
+267%
+90%
2024
$9.3M
$20.7M
$2.6M
+167%
+61%
2023
$7.7M
$17.4M
$1.8M
+85%
+38%
2022
$6.6M
$9.4M
$1.5M
+20%
+14%
2021
$6.5M
$6.1M
$1.8M
+9%
+22%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 276 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$2.5B
four quarters, 2025-06-29 to 2026-06-27
Revenue, TTM SPXC
FY Dec 2025
$2.3B
FY Dec 2024
$2.0B
FY Dec 2023
$1.7B
FY Dec 2022
$1.5B
FY Dec 2021
n/a
Jun 2026
$679.0M
Mar 2026
$566.8M
Dec 2025
$637.3M
Sep 2025
$592.8M
Jun 2025
$552.4M
Mar 2025
$482.6M
Dec 2024
$533.7M
Sep 2024
$483.7M
At each fiscal year end
Single quarter
Net margin, TTM
+11.3%
net income over revenue, 2025-06-29 to 2026-06-27
Net margin, TTM SPXC
FY Dec 2025
+10.8%
FY Dec 2024
+10.1%
FY Dec 2023
+5.2%
FY Dec 2022
+0.0%
FY Dec 2021
n/a
Jun 2026
+11.5%
Mar 2026
+10.6%
Dec 2025
+12.2%
Sep 2025
+10.6%
Jun 2025
+9.4%
Mar 2025
+10.6%
Dec 2024
+10.7%
Sep 2024
+10.4%
At each fiscal year end
Single quarter
Free cash flow, TTM
$303.4M
operating cash flow minus capex, 2025-06-29 to 2026-06-27
Free cash flow, TTM SPXC
FY Dec 2025
$241.2M
FY Dec 2024
$247.9M
FY Dec 2023
$184.6M
FY Dec 2022
-$152.7M
FY Dec 2021
$165.0M
Jun 2026
$68.5M
Mar 2026
$12.1M
Dec 2025
$126.7M
Sep 2025
$96.1M
Jun 2025
$34.8M
Mar 2025
-$16.4M
Dec 2024
$156.7M
Sep 2024
$43.5M
At each fiscal year end
Single quarter
Debt to equity
0.23x
long-term 2026-06-27 plus current 2026-06-27; equity 2026-06-27
Debt to equity SPXC
FY Dec 2025
0.22x
FY Dec 2024
0.44x
FY Dec 2023
0.45x
FY Dec 2022
0.23x
FY Dec 2021
0.22x
Jun 2026
0.23x
Mar 2026
0.28x
Dec 2025
0.22x
Sep 2025
0.23x
Jun 2025
0.64x
Mar 2025
0.62x
Dec 2024
0.44x
Sep 2024
0.51x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
0.78x
TTM operating cash flow over long-term 2026-06-27 plus current 2026-06-27
Cash flow to debt SPXC
FY Dec 2025
0.67x
FY Dec 2024
0.47x
FY Dec 2023
0.39x
FY Dec 2022
-0.56x
FY Dec 2021
0.72x
Jun 2026
0.78x
Mar 2026
0.58x
Dec 2025
0.67x
Sep 2025
0.61x
Jun 2025
0.26x
Mar 2025
0.29x
Dec 2024
0.47x
Sep 2024
0.36x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+14.4%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on equity SPXC
FY Dec 2025
+13.5%
FY Dec 2024
+15.5%
FY Dec 2023
+7.9%
FY Dec 2022
+0.0%
FY Dec 2021
+48.8%
Jun 2026
+14.4%
Mar 2026
+13.6%
Dec 2025
+13.5%
Sep 2025
+12.7%
Jun 2025
+15.0%
Mar 2025
+15.1%
Dec 2024
+15.5%
Sep 2024
+14.0%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+7.7%
TTM net income over average of 2025-06-28 and 2026-06-27
Return on assets SPXC
FY Dec 2025
+7.7%
FY Dec 2024
+7.8%
FY Dec 2023
+4.1%
FY Dec 2022
+0.0%
FY Dec 2021
+17.1%
Jun 2026
+7.7%
Mar 2026
+7.2%
Dec 2025
+7.7%
Sep 2025
+7.1%
Jun 2025
+6.9%
Mar 2025
+6.8%
Dec 2024
+7.8%
Sep 2024
+6.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+13.4%
operating income after a 22.1% effective tax rate, over long-term 2026-06-27 plus current 2026-06-27 plus average of 2025-06-28 and 2026-06-27 minus cash
Return on invested capital SPXC
FY Dec 2025
+13.4%
FY Dec 2024
+13.8%
FY Dec 2023
+11.1%
FY Dec 2022
+3.5%
FY Dec 2021
+7.0%
Jun 2026
+13.4%
Mar 2026
+12.2%
Dec 2025
+13.4%
Sep 2025
+12.8%
Jun 2025
+11.1%
Mar 2025
+11.5%
Dec 2024
+13.8%
Sep 2024
+12.4%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+13.0%
operating income (EBIT proxy) over average of 2025-06-28 and 2026-06-27 minus current liabilities
Return on capital employed SPXC
FY Dec 2025
+12.9%
FY Dec 2024
+14.2%
FY Dec 2023
+12.2%
FY Dec 2022
+2.7%
FY Dec 2021
+3.7%
Jun 2026
+13.0%
Mar 2026
+12.3%
Dec 2025
+12.9%
Sep 2025
+12.7%
Jun 2025
+12.9%
Mar 2025
+13.0%
Dec 2024
+14.2%
Sep 2024
+13.0%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
29.05x
close 2026-10-26 over four quarters of diluted EPS, 2025-06-29 to 2026-06-27
P/E, trailing SPXC
FY Dec 2025
39.85x
FY Dec 2024
34.16x
FY Dec 2023
52.34x
FY Dec 2022
1,182,645,289,635,282,944.00x
FY Dec 2021
6.54x
Jun 2026
41.63x
Mar 2026
39.06x
Dec 2025
39.85x
Sep 2025
39.09x
Jun 2025
37.48x
Mar 2025
30.10x
Dec 2024
34.16x
Sep 2024
42.64x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$8.5B
market value at close 2026-10-26 on 2026-07-24 shares, plus long-term 2026-06-27 plus current 2026-06-27, minus cash 2026-06-27
Enterprise value SPXC
FY Dec 2025
$10.1B
FY Dec 2024
$7.2B
FY Dec 2023
$5.1B
FY Dec 2022
$3.1B
FY Dec 2021
$2.6B
Jun 2026
$12.0B
Mar 2026
$10.5B
Dec 2025
$10.1B
Sep 2025
$8.8B
Jun 2025
$8.7B
Mar 2025
$6.7B
Dec 2024
$7.2B
Sep 2024
$7.9B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+3.7%
TTM free cash flow over market value at close 2026-10-26
FCF yield SPXC
FY Dec 2025
+2.4%
FY Dec 2024
+3.7%
FY Dec 2023
+4.0%
FY Dec 2022
-5.1%
FY Dec 2021
+6.1%
Jun 2026
+2.6%
Mar 2026
+2.7%
Dec 2025
+2.4%
Sep 2025
+3.2%
Jun 2025
+2.8%
Mar 2025
+3.8%
Dec 2024
+3.7%
Sep 2024
+2.9%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.17x
P/E over trailing EPS growth of 25%: four quarters to 2026-06-27 against the four to 2025-06-28
PEG, trailing SPXC
FY Dec 2025
2.23x
FY Dec 2024
0.28x
FY Dec 2023
0.00x
FY Dec 2022
n/a
FY Dec 2021
0.02x
Jun 2026
1.67x
Mar 2026
2.05x
Dec 2025
2.23x
Sep 2025
1.53x
Jun 2025
0.37x
Mar 2025
0.28x
Dec 2024
0.28x
Sep 2024
0.09x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SPXC ranks highest on risk and compliance (80th percentile) and financial health (77th), and lowest on institutional and government (39th), among Industrials peers.
Profitability
65
Inputs
Return on equity+14.4% · 65 pct, sector of 198
Return on assets+7.7% · 73 pct, sector of 224
Return on invested capital+13.4% · 55 pct, sector of 107
Return on capital employed+13.0% · 69 pct, sector of 195
Financial health
77
Inputs
Debt to equity0.23x · 68 pct, sector of 215
Cash flow to debt0.78x · 85 pct, sector of 173
Growth
46
Inputs
Revenue growth, YoY+14.2% · 76 pct, sector of 255
Backlog growth, YoY-20.9% · 16 pct, sector of 90
Institutional and government
39
Inputs
Funds adding, latest quarter276 · 69 pct, sector of 200
Congress net buyers, 365d-1 · 10 pct, sector of 43
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
80
Inputs
Short interest, % of float+3.4% · 59 pct, sector of 271
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 192
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
2 not measured: Insider conviction, US patents
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
5 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SPXC filings, in plain words
Have members of Congress traded SPXC?
Yes. In the year to 2026-10-28, 0 House members disclosed buying SPXC and 1 House member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-07-16.
Read the full summary
In the year to 2026-10-28, 0 members of Congress disclosed buying SPXC and 1 member disclosed selling it; the latest on record is a sale by Gilbert Cisneros dated 2026-07-16. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.